Carlos López
University of Mendoza(AR)Universidad de Cantabria(ES)Marqués de Valdecilla University Hospital(ES)Instituto de Investigación Marqués de Valdecilla(ES)Hospital Universitario Ramón y Cajal(ES)
Publications by Year
Research Areas
Neuroendocrine Tumor Research Advances, Lung Cancer Research Studies, Colorectal Cancer Treatments and Studies, Pancreatic and Hepatic Oncology Research, Hepatocellular Carcinoma Treatment and Prognosis
Most-Cited Works
- → Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial(2018)5,305 cited
- → High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non–small-cell lung cancer: Long-term results of a radiation dose escalation study(2005)495 cited
- → Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study(2018)342 cited
- → Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer(2017)191 cited
- → Lenvatinib versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma: patient-reported outcomes from a randomised, open-label, non-inferiority, phase 3 trial(2021)144 cited